Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genycell Biotech is an established Spanish biotechnology company specializing in providing innovative products, reagents, and technologies for life sciences research, human genetics, molecular biology, cell biology, cytogenetics, NGS applications, and tissue-related 3D models. It serves academic researchers as well as diagnostic labs and the pharmaceutical/biotechnology industry. The company also co-develops new products through its R&D department in Spain. Since 2019 it has been part of a leading Spanish genetic diagnostics group formed by Alantra Private Equity through the integration of Imegen, Health in Code, and Genycell Biotech. It operates mainly as a solutions provider/distributor rather than developing its own clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genycell Biotech.